Coverage
-
February 12, 2014
A California federal judge on Wednesday allowed Avanir Pharmaceuticals Inc.'s shareholder vote on issues like executive pay to proceed despite the objections of a putative class of investors claiming that its proxy notice was misleading, ruling all the information required for an informed vote was in the notice.
1 other articles on this case.
View all »